Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 2.150
-0.100 (-4.44%)
Aug 28, 2026, 4:10 PM AEST
Racura Oncology Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 34.29 | 13.67 | 17.19 | 21.52 | 33.54 |
Cash & Short-Term Investments | 34.29 | 13.67 | 17.19 | 21.52 | 33.54 |
Cash Growth | 150.92% | -20.50% | -20.13% | -35.84% | 259.79% |
Other Receivables | 0.08 | 0.03 | 0.11 | 1.7 | 0.06 |
Receivables | 0.08 | 0.03 | 0.11 | 1.7 | 0.06 |
Prepaid Expenses | 0.24 | 1.26 | 0.12 | 0.32 | 0.55 |
Total Current Assets | 34.61 | 14.96 | 17.42 | 23.54 | 34.15 |
Property, Plant & Equipment | 0 | - | - | - | - |
Other Intangible Assets | 2.25 | 2.53 | 2.81 | 3.09 | 3.37 |
Other Long-Term Assets | 1.23 | - | - | - | - |
Total Assets | 38.09 | 17.49 | 20.23 | 26.64 | 37.52 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 0.46 | 0.46 | 1.2 | 0.64 | 0.83 |
Accrued Expenses | 1.1 | 0.97 | 0.67 | 0.51 | 0.58 |
Other Current Liabilities | 0.05 | 0.02 | - | - | - |
Total Current Liabilities | 1.61 | 1.45 | 1.87 | 1.15 | 1.42 |
Other Long-Term Liabilities | 0.03 | 0.02 | 0.05 | - | - |
Total Liabilities | 1.64 | 1.48 | 1.92 | 1.15 | 1.42 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 101 | 68.49 | 66.95 | 61.71 | 62.02 |
Retained Earnings | -73.29 | -62.21 | -57.42 | -43.6 | -33.68 |
Comprehensive Income & Other | 8.74 | 9.73 | 8.78 | 7.38 | 7.77 |
Shareholders' Equity | 36.45 | 16.01 | 18.31 | 25.49 | 36.11 |
Total Liabilities & Equity | 38.09 | 17.49 | 20.23 | 26.64 | 37.52 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Cash (Debt) | 34.29 | 13.67 | 17.19 | 21.52 | 33.54 |
Net Cash Growth | 150.92% | -20.50% | -20.13% | -35.84% | 259.79% |
Net Cash Per Share | 0.19 | 0.08 | 0.10 | 0.13 | 0.22 |
Filing Date Shares Outstanding | 196.07 | 173.74 | 170.39 | 163.07 | 159.52 |
Total Common Shares Outstanding | 196.07 | 173.74 | 170.3 | 163.07 | 159.52 |
Working Capital | 33 | 13.51 | 15.55 | 22.39 | 32.73 |
Book Value Per Share | 0.19 | 0.09 | 0.11 | 0.16 | 0.23 |
Tangible Book Value | 34.2 | 13.48 | 15.5 | 22.39 | 32.73 |
Tangible Book Value Per Share | 0.17 | 0.08 | 0.09 | 0.14 | 0.21 |